Psychedelics Terran Biosciences obtains U.S. patent approval for catalogue of novel psychedelics They include two new forms of psilocybin, orally active DMT and 5-MeO-DMT, and an ibogaine derivative Rowan DunneDecember 11, 2023
Psychedelics California startup Tactogen gets U.S. patent for MDMA derivatives The company focuses on developing novel psychoactive drugs with more gentle effects Rowan DunneSeptember 27, 2023
Alternative Energy Standard Lithium progresses patents on its lithium extraction methods 'Process for Recovering Lithium from Brines' is the title of two novel DLE methods developed by the company Rowan DunneNovember 2, 2022
Psychedelics Small Pharma acquires U.S. patent for its DMT compounds The company has enhanced its IP portfolio with a patent that will be valid until 2041 Rowan DunneOctober 21, 2022
Business Avicanna files patent for cannabinoid med that reduces epileptic seizures, sudden death A number of the medical cannabis maker's products are available to Canadian patients Natalia Buendia CalvilloSeptember 24, 2021